Ylangenyl acetateCAS# 90039-63-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 90039-63-7 | SDF | Download SDF |
| PubChem ID | 14021304 | Appearance | Oil |
| Formula | C17H26O2 | M.Wt | 262.39 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC(C)C1CCC2(C3C1C2C(=CC3)COC(=O)C)C | ||
| Standard InChIKey | OBDVJFXOTPVHBB-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C17H26O2/c1-10(2)13-7-8-17(4)14-6-5-12(9-19-11(3)18)16(17)15(13)14/h5,10,13-16H,6-9H2,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Targets | PGE | NOS | COX | EGFR |
Ylangenyl acetate Dilution Calculator
Ylangenyl acetate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.8111 mL | 19.0556 mL | 38.1112 mL | 76.2224 mL | 95.278 mL |
| 5 mM | 0.7622 mL | 3.8111 mL | 7.6222 mL | 15.2445 mL | 19.0556 mL |
| 10 mM | 0.3811 mL | 1.9056 mL | 3.8111 mL | 7.6222 mL | 9.5278 mL |
| 50 mM | 0.0762 mL | 0.3811 mL | 0.7622 mL | 1.5244 mL | 1.9056 mL |
| 100 mM | 0.0381 mL | 0.1906 mL | 0.3811 mL | 0.7622 mL | 0.9528 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Detomidine HCl
Catalog No.:BCC4346
CAS No.:90038-01-0
- PFI 4
Catalog No.:BCC6484
CAS No.:900305-37-5
- Agar (bacteriological)
Catalog No.:BCC1208
CAS No.:9002-18-0
- PIK-294
Catalog No.:BCC4995
CAS No.:900185-02-6
- PIK-293
Catalog No.:BCC4994
CAS No.:900185-01-5
- Boc-Ser(PO3Bzl2)-OH
Catalog No.:BCC3443
CAS No.:90013-45-9
- 4,4'-Bis(diethylamino)benzophenone
Catalog No.:BCC8659
CAS No.:90-93-7
- Lobelin
Catalog No.:BCN2157
CAS No.:90-69-7
- 6-Amino-4-hydroxy-2-naphthalenesulfonic acid
Catalog No.:BCC8761
CAS No.:90-51-7
- 3,4,5-Trimethoxycinnamic acid
Catalog No.:BCN5030
CAS No.:90-50-6
- Xanthone
Catalog No.:BCC6493
CAS No.:90-47-1
- 4-Methylumbelliferone
Catalog No.:BCN2563
CAS No.:90-33-5
- Inulin
Catalog No.:BCC4789
CAS No.:9005-80-5
- PF-3274167
Catalog No.:BCC6451
CAS No.:900510-03-4
- AS-252424
Catalog No.:BCC4988
CAS No.:900515-16-4
- 5-O-beta-D-Glucopyranosylmyricanol
Catalog No.:BCN8044
CAS No.:90052-02-1
- Chondroitin sulfate
Catalog No.:BCN1312
CAS No.:9007-28-7
- AVX 13616
Catalog No.:BCC5407
CAS No.:900814-48-4
- Rebamipide
Catalog No.:BCC4836
CAS No.:90098-04-7
- TAME
Catalog No.:BCC4367
CAS No.:901-47-3
- Fostamatinib (R788)
Catalog No.:BCC5082
CAS No.:901119-35-5
- GSK 5959
Catalog No.:BCC5597
CAS No.:901245-65-6
- Gossypolone
Catalog No.:BCC1375
CAS No.:4547-72-2
- AT7519 Hydrochloride
Catalog No.:BCC1376
CAS No.:902135-91-5
Inhibitory effects of beta-chamigrenal, isolated from the fruits of Schisandra chinensis, on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in RAW 264.7 macrophages [corrected].[Pubmed:24871206]
Planta Med. 2014 Jun;80(8-9):655-61.
Much is known about the bioactive properties of lignans from the fruits of Schisandra chinensis. However, very little work has been done to determine the properties of sesquiterpenes in the fruits of S. chinensis. The aim of the present study was to investigate the anti-inflammatory potential of new sesquiterpenes (beta-chamigrenal, beta-chamigrenic acid, alpha-ylangenol, and alpha-Ylangenyl acetate) isolated from the fruits of S. chinensis and to explore their effect on macrophages stimulated with lipopolysaccharide. Of these four sesquiterpenes, beta-chamigrenal most significantly suppressed lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in RAW 264.7 macrophages (47.21 +/- 4.54 % and 51.61 +/- 3.95 % at 50 microM, respectively). Molecularly, the inhibitory activity of beta-chamigrenal on nitric oxide production was mediated by suppressing inducible nitric oxide synthase activity but not its expression. In the prostaglandin E2 synthesis pathway, beta-chamigrenal prevented the upregulation of inducible microsomal prostaglandin E synthase-1 expression after stimulation with lipopolysaccharide. Conversely, beta-chamigrenal had no effect on the expression and enzyme activity of cyclooxygenase-2. In addition, the expression of early growth response factor-1, a key transcription factor of microsomal prostaglandin E synthase-1 expression, was inhibited by beta-chamigrenal. These results may suggest a possible anti-inflammatory activity of beta-chamigrenal which has to be proven in in vivo experiments.
